TP53 and Parkinson disease: While increased p53 activity in PD promoted neuronal apoptosis [30, 31], dopaminergic neuron-specific deletion and pharmacological inhibition of p53 reduced the loss of dopaminergic neuron [31] and motor deficits [32, 33], respectively.